Paper41718166
The Role of Metabolites in Acyclovir-Induced Neurotoxicity and Nephrotoxicity.
Aboelezz A and 1 other. Medicines (Basel), 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. The Role of Metabolites in Acyclovir-Induced Neurotoxicity and Nephrotoxicity. Papers, record 41718166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41718166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20558439 | Mitochondrial aldehyde dehydrogenase and cardiac diseases. | Cardiovasc Res | 2010 | https://conductscience.org/library/papers/20558439 | PubMed |
| 2 | 9610386 | Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. | Biochem Biophys Res Commun | 1998 | https://conductscience.org/library/papers/9610386 | PubMed |
| 3 | 25055032 | Proteomic characterization of acyclovir-induced nephrotoxicity in a mouse model. | PLoS One | 2014 | https://conductscience.org/library/papers/25055032 | PubMed |
| 4 | 17651180 | Acyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patient. | Int J Dermatol | 2007 | https://conductscience.org/library/papers/17651180 | PubMed |
| 5 | 8149891 | Metabolic disposition of the acyclovir prodrug valaciclovir in the rat. | Drug Metab Dispos | 1994 | https://conductscience.org/library/papers/8149891 | PubMed |
| 6 | 28002877 | The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database. | Br J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/28002877 | PubMed |
| 7 | 36228373 | Therapeutic monitoring of serum concentrations of acyclovir and its metabolite 9-(carboxymethoxymethyl) guanine in routine clinical practice. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/36228373 | PubMed |
| 8 | 6285711 | Renal function after acyclovir intravenous injection. | Am J Med | 1982 | https://conductscience.org/library/papers/6285711 | PubMed |
| 9 | 25440915 | Aciclovir-induced neurotoxicity: Utility of CSF and serum CMMG levels in diagnosis. | J Clin Virol | 2014 | https://conductscience.org/library/papers/25440915 | PubMed |
| 10 | 36601749 | Aciclovir-induced neurotoxicity. | Pract Neurol | 2023 | https://conductscience.org/library/papers/36601749 | PubMed |
| 11 | 7103460 | Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/7103460 | PubMed |
| 12 | 31504577 | An unexpectedly high occurrence of aciclovir-induced neuropsychiatric symptoms in patients treated for herpesvirus CNS infection: a prospective observational study. | J Antimicrob Chemother | 2019 | https://conductscience.org/library/papers/31504577 | PubMed |
| 13 | 31171414 | Neurologic Acyclovir Toxicity in the Absence of Kidney Injury. | J Emerg Med | 2019 | https://conductscience.org/library/papers/31171414 | PubMed |
| 14 | 6291456 | Mode of action of acyclovir triphosphate on herpesviral and cellular DNA polymerases. | Antiviral Res | 1982 | https://conductscience.org/library/papers/6291456 | PubMed |
| 15 | 3881542 | Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. | J Infect Dis | 1985 | https://conductscience.org/library/papers/3881542 | PubMed |
| 16 | 38364888 | Acyclovir dosing in herpes encephalitis: A scoping review. | J Am Pharm Assoc (2003) | 2024 | https://conductscience.org/library/papers/38364888 | PubMed |
| 17 | 19252116 | Herpes zoster (shingles) and postherpetic neuralgia. | Mayo Clin Proc | 2009 | https://conductscience.org/library/papers/19252116 | PubMed |
| 18 | 16417045 | Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. | Crit Rev Toxicol | 2005 | https://conductscience.org/library/papers/16417045 | PubMed |
| 19 | 40188662 | Acyclovir dosing strategies in herpes encephalitis: A retrospective charts review. | J Clin Neurosci | 2025 | https://conductscience.org/library/papers/40188662 | PubMed |
| 20 | 9739972 | Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group. | JAMA | 1998 | https://conductscience.org/library/papers/9739972 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42702568 | Use of fomepizole as a novel approach for preventing aciclovir-induced neurotoxicity. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/42702568 | PubMed |
| 42158733 | The utility of pyrimidine derivatives in the construction of azolo[d]pyrimidine: part II-multi-nitrogen azole systems with potential biological applications. | RSC Adv | 2026 | https://conductscience.org/library/papers/42158733 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41718166
GET https://conductscience.org/api/papers/v1/41718166/references?page=2